Story · Medicine & Biotech
Christian Capitini: FDA Finalizes Guidance to Broaden Clinical Trial Eligibility and Expand Patient Access to Experimental Therapies
1 outlet · first reported by OncoDaily 2d ago
Coverage, in order
-
2d ago
Christian Capitini: FDA Finalizes Guidance to Broaden Clinical Trial Eligibility and Expand Patient Access to Experimental TherapiesChristian Capitini, Director of UW Carbone Cancer Center, shared on LinkedIn: “FDA finalizes guidance to broaden clinical trial eligibility. We should widen inclusion/exclusion criteria as much as feasible. Clinical trials
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.